Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
作者信息
Kim Jong Man
机构信息
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2021 Oct;27(4):562-563. doi: 10.3350/cmh.2021.0276. Epub 2021 Sep 23.
Abstract
摘要
相似文献
1
Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
Clin Mol Hepatol. 2021 Oct;27(4):562-563. doi: 10.3350/cmh.2021.0276. Epub 2021 Sep 23.
2
Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma.
Hepatology. 1997 Dec;26(6):1689-91. doi: 10.1002/hep.510260650.
3
Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries?
Liver Transpl. 2009 Jul;15(7):822-3; author reply 824-6. doi: 10.1002/lt.21765.
4
Contemporary Changes in Etiology for Hepatocellular Carcinoma in Liver Transplantation.
Clin Gastroenterol Hepatol. 2023 Aug;21(9):2410-2412.e1. doi: 10.1016/j.cgh.2022.07.009. Epub 2022 Jul 20.
5
[Liver transplantation for hepatocellular carcinoma. Mid-term results].
Presse Med. 1992 Nov 21;21(39):1846-8.
6
Immunosuppression and hepatocellular carcinoma.
Liver Transpl. 2011 Oct;17 Suppl 2:S159-61. doi: 10.1002/lt.22318.
7
Liver transplantation for hepatocellular carcinoma.
Hepatogastroenterology. 2002 Jan-Feb;49(43):47-52.
8
Rapid fibrosis and significant histologic recurrence of hepatitis C after liver transplant is associated with higher tumor recurrence rates in hepatocellular carcinomas associated with hepatitis C virus-related liver disease: a single center retrospective analysis.
Exp Clin Transplant. 2015 Feb;13(1):46-50.
9
[Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis].
Gastroenterol Clin Biol. 1997;21(8-9):590-5.
10
Unusual presentation of recurrent hepatocellular carcinoma as obstructive jaundice 15 years after liver transplant.
Exp Clin Transplant. 2007 Dec;5(2):713-5.
引用本文的文献
1
Association between the early high level of serum tacrolimus and recurrence of hepatocellular carcinoma in ABO-incompatible liver transplantation.
World J Gastrointest Surg. 2023 Dec 27;15(12):2727-2738. doi: 10.4240/wjgs.v15.i12.2727.
2
Comparison of the safety and efficacy of hepatic resection and radiofrequency ablation in the treatment of single small hepatocellular carcinoma: systematic review and meta-analysis.
Transl Cancer Res. 2022 Mar;11(3):580-590. doi: 10.21037/tcr-22-563.
本文引用的文献
1
Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma.
Clin Mol Hepatol. 2021 Oct;27(4):589-602. doi: 10.3350/cmh.2021.0038. Epub 2021 Jul 23.
2
Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation.
Ann Surg Treat Res. 2021 Jul;101(1):28-36. doi: 10.4174/astr.2021.101.1.28. Epub 2021 Jun 30.
3
Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials.
Transplantation. 2021 Jul 1;105(7):1564-1575. doi: 10.1097/TP.0000000000003394.
4
Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry.
Clin Mol Hepatol. 2021 Jul;27(3):451-462. doi: 10.3350/cmh.2020.0292. Epub 2021 Feb 2.
5
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors.
Ann Surg. 2020 Nov;272(5):855-862. doi: 10.1097/SLA.0000000000004280.
6
Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
Mayo Clin Proc. 2018 Sep;93(9):1236-1246. doi: 10.1016/j.mayocp.2018.04.025. Epub 2018 Jul 29.
7
Use of everolimus in liver transplantation.
World J Hepatol. 2017 Aug 18;9(23):990-1000. doi: 10.4254/wjh.v9.i23.990.
8
Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
Liver Transpl. 2017 Apr;23(4):440-447. doi: 10.1002/lt.24742.
9
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
Transplantation. 2016 Jan;100(1):116-25. doi: 10.1097/TP.0000000000000965.
10
Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.
Hepatology. 2010 Apr;51(4):1237-43. doi: 10.1002/hep.23437.
Zotero 插件